Insiders · SNOA

Vanessa Jacoby

Director at Sonoma Pharmaceuticals, Inc. (SNOA) since January 2026

Vanessa Jacoby has filed 2 insider reports with the SEC since February 2026, as director at Sonoma Pharmaceuticals, Inc. (SNOA). The latest filing, on July 10, 2026, reports grant or award at Sonoma Pharmaceuticals, Inc. (SNOA).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Vanessa Jacoby is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sonoma Pharmaceuticals, Inc. logo
SNOA
Sonoma Pharmaceuticals, Inc.
Directorsince January 2026$0.8097Jul 10, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Vanessa Jacoby with

Other insiders at the same companies

Questions about Vanessa Jacoby

What is Vanessa Jacoby's role at Sonoma Pharmaceuticals, Inc.?
Vanessa Jacoby reports to the SEC as director at Sonoma Pharmaceuticals, Inc. (SNOA), according to the latest filing on July 10, 2026.
Has Vanessa Jacoby bought or sold stock recently?
No open-market purchases or sales by Vanessa Jacoby are on file. The filings report grant or award.
How do I get alerts when Vanessa Jacoby files?
Follow Vanessa Jacoby on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Vanessa Jacoby (SEC CIK 0002110126). Totals count each trade once, skipping amendments whose original is on file, from Feb 9, 2026 on. View on SEC EDGAR · Get this as JSON